Parent Project Muscular Dystrophy (PPMD)

PPMD Applauds FDA for Landmark Approval of First-Ever Gene Therapy Treatment for Duchenne for Patients Ages 4-5 Years Old

by

Organization Will Continue to Support Patient Access and Drive Policies and Projects That Support Development and Approval of More Therapies WASHINGTON, June 22, 2023 /PRNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), heralded today’s decision by the Food and Drug Administration (FDA) to approve … Read more

Parent Project Muscular Dystrophy Announces Pediatric Certified Duchenne Care Center, Norton Children’s Hospital

by

Leading Duchenne Organization Expands Certification of Clinics that Provide Optimal Care for People with Duchenne Muscular Dystrophy with 1st Clinic in Kentucky WASHINGTON, June 20, 2023 /PRNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced the expansion of its renowned Certified Duchenne Care Center (CDCC) … Read more

Parent Project Muscular Dystrophy Announces Pediatric Certified Duchenne Care Center, Boston Children’s Hospital

by

Leading Duchenne Organization Expands Certification of Clinics that Provide Optimal Care for People with Duchenne Muscular Dystrophy with Clinic in Massachusetts WASHINGTON, June 16, 2023 /PRNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced the expansion of its renowned Certified Duchenne Care Center (CDCC) Program … Read more